UK markets open in 6 hours 29 minutes

NVO Jan 2024 125.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
14.920.00 (0.00%)
As of 02:56PM EST. Market open.
Full screen
Loading interactive chart…
  • Zacks

    Rigel (RIGL) Up on FDA Nod to Blood Cancer Drug Rezlidhia

    The FDA approves Rigel's (RIGL) Rezlidhia (olutasidenib) for treating relapsed/refractory acute myeloid leukemia with a susceptible IDH1 mutation. Stock up.

  • Globe Newswire

    Novo Nordisk A/S – Share repurchase programme

    Bagsværd, Denmark, 30 November 2022 – On 4 November 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 24 billion to be executed during a 12-month period beginning 2 February 2022. Under the programm

  • Motley Fool

    3 Healthcare Stocks That Could Set You Up For Life

    Until that day, companies in the healthcare sector that can stay ahead of the curve will continue to thrive. Although this market is competitive, the company made its name by targeting the life sciences industry. In other words, Veeva Systems is a specialist, not a generalist.